Treatment with bevacizumab for ocular vascular lesions
Not Applicable
Recruiting
- Conditions
- Ocular vascular lesions
- Registration Number
- JPRN-UMIN000020916
- Lead Sponsor
- Keio University, School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 1000
Inclusion Criteria
Not provided
Exclusion Criteria
Those who cannot understand the impact of the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Ocular findings including best-corrected visual acuity and fundus findings 6 months after initial injection
- Secondary Outcome Measures
Name Time Method